Sinovac Biotech

Daga Wikipedia, Insakulofidiya ta kyauta.
Jump to navigation Jump to search

 

Sinovac Biotech Ltd. girma ( Chinese , Nasdaq ) wani kamfani ne na likitancin halittu na kasar Sin wanda ke mai da hankali kan bincike, haɓakawa, ƙira, da kuma tallata rigakafin da ke ba da kariya ga cututtukan ɗan adam . Kamfanin yana zaune ne a gundumar Haidian, Beijing a kasar Sin.[1] An jera kamfanin akan NASDAQ amma musayar ta dakatar da cinikin Sinovac a watan Fabrairun 2019 saboda yakin wakili.[2][3] Kamfanin ya fuskanci binciken cin hanci a China.[2]

Magungunan rigakafi[gyara sashe | Gyara masomin]

Maganin sayar da Sinovac sun haɗa da CoronaVac ( alurar rigakafin COVID-19 ), Inlive ( alurar rigakafin Enterovirus 71 ), Anflu ( alurar rigakafin mura ), Healive (alurar rigakafin hanta A ), maganin varicella da rigakafin mumps .[4]

Ci gaban rigakafin COVID-19[gyara sashe | Gyara masomin]

CoronaVac kwayar cuta ce da ba a kunna ta ba ta COVID-19 wacce Sinovac ta kirkira.[5] Ya kasance a cikin gwajin asibiti na Phase III a Brazil,[6] Chile,[7] Indonesia,[8] Philippines,[9] da Turkiyya .[10]

Ya dogara da fasahar gargajiya irin ta BBIBP-CorV da BBV152, in ba haka ba an san su da allurar rigakafin cutar COVID-19 da ba a kunna ba a cikin gwaji na Mataki na III.[11] CoronaVac baya buƙatar daskarewa, kuma duka alluran rigakafi da kayan da za a ƙirƙira sabbin allurai ana iya jigilar su kuma a sanya su cikin firiji a 2-8 °C (36-46 °F), yanayin yanayin da ake kiyaye rigakafin mura.[12]

Wani bincike na hakika na miliyoyin mutanen Chilean goma da suka karɓi CoronaVac ya gano yana da tasiri 66% akan alamun COVID-19, 88% akan asibiti, 90% akan shigar da ICU, da 86% akan mace-mace.[13] A Brazil, bayan kashi 75% na yawan jama'a a Serrana, São Paulo ya karɓi CoronaVac, sakamakon farko ya nuna mutuwar mutane da kashi 95%, asibitoci da kashi 86%, da alamun alamun cutar da kashi 80%.[14][15] A Indonesiya, bayanan duniya na gaske daga ma'aikatan kiwon lafiya 128,290 sun nuna kariyar kashi 94% daga kamuwa da cutar ta hanyar allurar, inda ta doke sakamakon gwajin asibiti.[16]

Sakamako na uku daga Turkiyya da aka buga a cikin The Lancet ya nuna ingancin 84% bisa ga mahalarta 10,218 a cikin gwaji.[17][18] Sakamakon mataki na III daga Brazil a baya ya nuna ingancin kashi 50.7% wajen hana kamuwa da cututtuka da kuma kashi 83.7% yana da tasiri wajen hana cututtuka masu laushi da ke buƙatar magani. Ingancin kamuwa da cututtukan alamomi ya karu zuwa 62.3% tare da tazara na kwanaki 21 ko fiye tsakanin allurai.[19]

Ana amfani da CoronaVac a cikin kamfen ɗin rigakafi a ƙasashe daban-daban na Asiya, [20][21][22] Kudancin Amurka,[23][24][25] Arewacin Amurka,[26][27][28] da Turai.[29][30][31] Ya zuwa Afrilu 2021, Sinovac yana da ikon samar da allurai biliyan biyu a shekara[32] kuma ya ba da jimillar allurai miliyan 600.[33] A halin yanzu ana kera shi a wurare da yawa a China,[32] Brazil,[34] da Masar.[35] A ranar 1 ga Yuni 2021, Hukumar Lafiya ta Duniya (WHO) ta tabbatar da rigakafin don amfani da gaggawa.[36][37][38] Sinovac ya rattaba hannu kan yarjejeniyoyin sayayya na allurai miliyan 380 daga COVAX .[39]

Duba kuma[gyara sashe | Gyara masomin]

  • CanSino Biologics
  • Sinopharm

Hanyoyin haɗi na waje[gyara sashe | Gyara masomin]

Manazarta[gyara sashe | Gyara masomin]

  1. "Home (English)". Sinovac. Retrieved 2021-03-06. Add: No. 39 Shangdi Xi Road, Haidian District, Beijing, P.R.C. 100085
  2. 2.0 2.1 Dou, Eva (December 4, 2020). "As China nears a coronavirus vaccine, bribery cloud hangs over drugmaker Sinovac". The Washington Post (in Turanci). ISSN 0190-8286. Archived from the original on December 4, 2020. Retrieved 2020-12-06.
  3. Levine, Matt (May 22, 2020). "A Vaccine With a Poison Pill". Bloomberg News. Archived from the original on June 21, 2020. Retrieved December 6, 2020.
  4. "Vaccines". sinovac.com. Retrieved 1 September 2021.
  5. Nidhi Parekh (22 July 2020). "CoronaVac: A COVID-19 Vaccine Made From Inactivated SARS-CoV-2 Virus". Retrieved 25 July 2020.
  6. "New coronavirus vaccine trials start in Brazil". AP News. 21 July 2020. Retrieved 2020-10-07.
  7. "Chile initiates clinical study for COVID-19 vaccine". Chile Reports. 4 August 2020. Retrieved 2020-10-07.
  8. "248 volunteers have received Sinovac vaccine injections in Bandung". Antara News. 30 August 2020. Retrieved 2020-10-07.
  9. "248 volunteers have received Sinovac vaccine injections in Bandung". Antara News. 30 August 2020. Retrieved 2020-10-07.
  10. "Turkey begins phase three trials of Chinese Covid-19 vaccine". TRT World News. 1 September 2020. Retrieved 2020-10-07.
  11. Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee. "Coronavirus Vaccine Tracker". The New York Times (in Turanci). ISSN 0362-4331. Retrieved 2021-02-12.
  12. "CoronaVac: Doses will come from China on nine flights and can..." AlKhaleej Today (in Larabci). 2020-11-01. Retrieved 2021-02-12.
  13. Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. (July 2021). "Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile". The New England Journal of Medicine. 385 (10): 875–884. doi:10.1056/NEJMoa2107715. PMC 8279092 Check |pmc= value (help). PMID 34233097 Check |pmid= value (help). S2CID 235766915 Check |s2cid= value (help).
  14. Savarese M (2021-06-01). "Sinovac vaccine restores a Brazilian city to near normal". CTV News. Retrieved 2021-06-02.
  15. Pearson S (2021-05-31). "Brazil's Experiment to Vaccinate Town With Chinese CoronaVac Reduced Covid-19 Deaths by 95%". The Wall Street Journal. ISSN 0099-9660. Retrieved 2021-06-02.
  16. "China Sinovac Shot Seen Highly Effective in Real World Study". MSN. 12 May 2021. Retrieved 12 May 2021.
  17. Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, et al. (8 July 2021). "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey". The Lancet (in English). 398 (10296): 213–222. doi:10.1016/S0140-6736(21)01429-X. ISSN 0140-6736. PMC 8266301 Check |pmc= value (help). PMID 34246358 Check |pmid= value (help). S2CID 235770533 Check |s2cid= value (help).CS1 maint: unrecognized language (link)
  18. Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine (PDF) (Presentation). World Health Organization. 29 April 2021. Retrieved 10 July 2021.
  19. Costa A (2021-04-11). "Estudo clínico que comprova maior eficácia da Coronavac é enviado para Lancet" [Clinical study proving greater efficacy of Coronavac is submitted to The Lancet]. CNN Brasil (in Portuguese). São Paulo. Retrieved 2021-04-12.CS1 maint: unrecognized language (link)
  20. TARIGAN, EDNA; MILKO, VICTORIA (13 January 2021). "Indonesia starts mass COVID vaccinations over vast territory". Associated Press. Retrieved 15 January 2021.
  21. "Thailand Kicks Off Covid-19 Vaccine Program With Sinovac Shots". Bloomberg.com (in Turanci). Retrieved 28 February 2021.
  22. "China approves Sinovac vaccines for general public use". South China Morning Post (in Turanci). 6 February 2021. Retrieved 6 February 2021.
  23. Rochabrun, Marcelo. "Brazil health ministry says plans to order 30 million more Coronavac doses | The Chronicle Herald". www.thechronicleherald.ca (in Turanci). Retrieved 26 February 2021.
  24. Miranda, Natalia A. Ramos (28 January 2021). "Chile receives two million-dose first delivery of Sinovac COVID-19 vaccine". Reuters (in Turanci). Retrieved 30 January 2021.
  25. "BNamericas - Uruguay prepares to launch COVID-19 vaccinat..." BNamericas.com. Retrieved 1 March 2021.
  26. "Venustiano Carranza next up for Covid vaccination in Mexico City". Mexico News Daily. 2021-03-15. Retrieved 2021-03-16.
  27. "Anticovid vaccines run out as Dominican Republic awaits arrival of more doses". Dominican Today (in Turanci). Retrieved 2021-03-10.
  28. "Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac". Noticias de El Salvador - La Prensa Gráfica | Informate con la verdad (in Sifaniyanci). Retrieved 2021-03-28.
  29. "Turkey aims to vaccinate 60 percent of population: Minister – Turkey News". Hürriyet Daily News (in Turanci). Retrieved 12 February 2021.
  30. "Vaccination with CoronaVac launched in Ukraine on April 13 – Health minister". www.unian.info (in Turanci). Retrieved 2021-04-15.
  31. Semini, Llazar. "Albania starts mass COVID vaccinations before tourist season". ABC News (in Turanci). Retrieved 2021-03-28.
  32. 32.0 32.1 Liu, Roxanne (2021-04-02). "China Sinovac says it reached two billion doses annual capacity for COVID-19 vaccine". Reuters (in Turanci). Retrieved 2021-04-02.
  33. Nebehay, Stephanie (2021-06-01). "WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed". Reuters. Geneva. Retrieved 2021-06-01.
  34. Mano A, Simões (10 December 2020). "Chinese vaccine draws demand across Latin America, say Brazilian officials". Reuters (in Turanci). Archived from the original on 10 December 2020. Retrieved 10 December 2020.
  35. "Egypt to produce up to 80 million Sinovac vaccine doses annually". Arab News (in Turanci). 2021-04-08. Retrieved 2021-04-08.
  36. Nebehay S (2021-06-01). "WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed". Reuters. Geneva. Retrieved 2021-06-01.
  37. "WHO recommendation Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac". World Health Organization (WHO). 1 May 2021. Retrieved 1 June 2021.
  38. "WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations". World Health Organization (WHO) (Press release). Retrieved 1 June 2021.
  39. "Chinese drugmakers agree to supply more than half a billion vaccines to COVAX". Reuters. 2021-07-12. Retrieved 2021-07-13.